Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
RESEARCH TOOLSreports
OSE Immunotherapeutics SA (6OP) Ownership - Who Owns OSE Immunotherapeutics SA?
0 Followers
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 913 | Institution | ― | 5,432 | |
| 3,297 | Institution | ― | 19,617 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 913 | Institution | ― | 5,432 | |
| 3,297 | Institution | ― | 19,617 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns OSE Immunotherapeutics SA (DE:6OP)?
Currently, no data Available
What percentage of OSE Immunotherapeutics SA (DE:6OP) stock is held by institutional investors?
Currently, no data Available
What percentage of OSE Immunotherapeutics SA (DE:6OP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of OSE Immunotherapeutics SA (DE:6OP)?
John Hancock Funds II owns the most shares of OSE Immunotherapeutics SA (DE:6OP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.